IRBESARTAN/HIDROCLOROTIAZIDA AUROVITAS 150 mg/12,5 mg
The same active substance, strength and form as listed by each country’s medicines regulator. For showing a pharmacist abroad.
- Active substance
- Irbesartán + hidroclorotiazida
- Strength
- 150 mg/12,5 mg
- Form
- comprimido recubierto con película
- ATC code
- C09DA04
- Registered in
- Spain · Aurovitas Spain, S.A.U.
- Prescription
- Prescription only
- Nº Registro
- 81614
Source: CIMA — Centro de Información online de Medicamentos · 2026-09-30
Not a prescription. Not a statement that these products are interchangeable. Products are matched on active substance, strength and kind of form only. Other ingredients, release, approved uses and the dose on the box can differ. A pharmacist or doctor decides whether one can replace another.
Listed in other countries
Bulgaria 6 matching products
| Name on the box | Strength and form | Prescription | Holder | Official record |
|---|---|---|---|---|
| CO-IRBECКО-ИРБЕК | 150 mg/12,5 mg · tablets | Prescription only | Нео Балканика ЕООД | 20150316 |
| Co-IrbesanКо-Ирбесан | 150 mg/12,5 mg · film - coated tablets | Prescription only | НОБЕЛ ФАРМА ЕООД | 20130009 |
| Co-IrbessoКо-Ирбесо | 150 mg/12,5 mg · film - coated tablets | Prescription only | Чайкафарма Висококачествените Лекарства АД | 20110196 |
| CONVERIDEКОНВЕРИД | 150 mg/12,5 mg · film - coated tablets | Prescription only | Medochemie Ltd. | 20170340 |
| Irbecon-CoИрбекон-Ко | 150 mg/12,5 mg · film-coated tablets | Prescription only | ФАРМАКОНС АД | 20200178 |
| IrprezideИрпрезид | 150 mg/ 12.5 mg · film - coated tablets | Prescription only | Teva B.V. | 20110070 |
Source: Bulgarian Drug Agency register (Изпълнителна агенция по лекарствата (BDA)) · 2026-08-01
Canada 11 matching products
| Name on the box | Strength and form | Prescription | Holder | Official record |
|---|---|---|---|---|
| APO-IRBESARTAN/HCTZ | 150 mg + 12.5 mg · tablet | Prescription only | Apotex Inc | 02387646 |
| AURO-IRBESARTAN HCT | 150 mg + 12.5 mg · tablet | Prescription only | Auro Pharma Inc | 02447878 |
| AVALIDE | 150 mg + 12.5 mg · tablet | Prescription only | Sanofi-Aventis Canada Inc | 02241818 |
| IRBESARTAN AND HYDROCHLOROTHIAZIDE | 150 mg + 12.5 mg · tablet | Prescription only | Jubilant Generics Limited | 02404001 |
| IRBESARTAN HCT | 150 mg + 12.5 mg · tablet | Prescription only | Sivem Pharmaceuticals Ulc | 02385317 |
| IRBESARTAN/HCTZ | 150 mg + 12.5 mg · tablet | Prescription only | Sanis Health Inc | 02372886 |
5 more names not shown. Source: Drug Product Database (Health Canada) · 2026-09-30 · Contains information licensed under the Open Government Licence – Canada.
Netherlands 14 matching products
| Name on the box | Strength and form | Prescription | Holder | Official record |
|---|---|---|---|---|
| CoAprovel 150 mg/12 | 150 mg + 12,5 mg · filmomhulde tablet | Prescription only | Sanofi Winthrop Industrie (+1) | EU/1/98/086 |
| Irbesartan Hydrochlorothiazide Zentiva 150 mg/12 | 150 mg + 12,5 mg · tablet | Prescription only | Zentiva k.s. (+1) | EU/1/06/377 |
| Karvezide 150 mg/12 | 150 mg + 12,5 mg · tablet | Prescription only | Sanofi Winthrop Industrie (+1) | EU/1/98/085 |
| Converide 150mg/12 | 150mg + 12,5mg · filmomhulde tablet | Prescription only | Medochemie Limited | 113589 |
| Ifirmacombi 150 mg/12 | 150 mg + 12,5 mg · filmomhulde tablet | Prescription only | Krka d.d., Novo mesto | EU/1/11/673 |
| Irbesartan/HCT Jubilant 150 mg/12 | 150 mg + 12,5 mg · filmomhulde tablet | Prescription only | Jubilant Pharmaceuticals N.V. | 112346 |
5 more names not shown. Source: Geneesmiddeleninformatiebank (College ter Beoordeling van Geneesmiddelen (CBG-MEB)) · 2026-09-30 · Bron: College ter Beoordeling van Geneesmiddelen (CBG). De Rijksoverheid is het niet automatisch eens met de inhoud van deze site.
Same active substance, but no match for this strength and form
- European Union: 6 products · Every strength and form
- Switzerland: 15 products · Every strength and form